Skip to content

Akari reiterated as buy by Blair

April 24, 2017

Akari Therapeutics PLC (NASDAQ:AKTX)‘s stock had its “outperform” rating reiterated by research analysts at William Blair in a research report issued to clients and investors on Thursday.

http://bit.ly/2oCWLyH

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: